|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/2009 | (2013.01) |
| A61K 9/20 | (2006.01) | ||
| A61K 31/675 | (2006.01) | ||
| A61K 9/2013 | (2013.01) | ||
| A61K 31/00 | (2006.01) | ||
| A61K 9/2086 | (2013.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/2846 | (2013.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 19/08 | (2018.01) | ||
| A61P 19/10 | (2018.01) | ||
| A61P 3/14 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61P 5/18 | (2018.01) | ||
| A61P 5/20 | (2018.01) | ||
| A61P 5/22 | (2018.01) |
| (11) | Number of the document | 2283825 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10011938.7 |
| Date of filing the European patent application | 2005-04-14 | |
| (97) | Date of publication of the European application | 2011-02-16 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 573881 P | 2004-05-24 | US |
| (72) |
Dansereau, Richard John , US
Burgio, Ernest David, Jr. , US
|
| (73) |
Allergan Pharmaceuticals International Limited ,
Clonshaugh Industrial Estate
Coolock, Dublin 17,
IE
Theramex HQ UK Limited , Sloane Square House 1 Holbein Place, Belgravia Greater London SW1W 8NS, GB |
| (54) | Enteric solid oral dosage form of a bisphosphonate containing a chelating agent |
| Enteric solid oral dosage form of a bisphosphonate containing a chelating agent |